164
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Fasting Serum Levels of Potassium and Sodium in Relation to Long-Term Risk of Cancer in Healthy Men

ORCID Icon, , ORCID Icon, ORCID Icon, , & ORCID Icon show all
Pages 1-8 | Published online: 09 Jan 2020

References

  • Jansson B. Dietary, total body, and intracellular potassium-to-sodium ratios and their influence on cancer. Cancer Detect Prev. 1990;14:563–565.2224920
  • Jansson B. Potassium, sodium, and cancer: a review. J Environ Pathol Toxicol Oncol. 1996;15:65–73.9216787
  • Jiang S, Zhu L, Yang J, et al. Integrated expression profiling of potassium channels identifys KCNN4 as a prognostic biomarker of pancreatic cancer. Biochem Biophys Res Commun. 2017;494:113–119. doi:10.1016/j.bbrc.2017.10.07229050937
  • Kim YS, Kim Y, Choi JW, Oh HE, Lee JH. Genetic variants and risk of prostate cancer using pathway analysis of a genome-wide association study. Neoplasma. 2016;63:629–634. doi:10.4149/neo_2016_41827268928
  • Huang X, Jan LY. Targeting potassium channels in cancer. J Cell Biol. 2014;206:151–162. doi:10.1083/jcb.20140413625049269
  • Litan A, Langhans SA. Cancer as a channelopathy: ion channels and pumps in tumor development and progression. Front Cell Neurosci. 2015;9:86. doi:10.3389/fncel.2015.0008625852478
  • Peruzzo R, Biasutto L, Szabò I, Leanza L. Impact of intracellular ion channels on cancer development and progression. Eur Biophys J. 2016;45:685–707.27289382
  • Cázares-Ordoñez V, Pardo LA. Kv10.1 potassium channel: from the brain to the tumors. Biochem Cell Biol. 2017;95:531–536. doi:10.1139/bcb-2017-006228708947
  • Qian Y, Wong CC, Xu J, et al. Sodium channel subunit SCNN1B suppresses gastric cancer growth and metastasis via GRP78 degradation. Cancer Res. 2017;77:1968–1982. doi:10.1158/0008-5472.CAN-16-159528202509
  • Wang SH, Wang KL, Yang WK, Lee TH, Lo WY, Lee JD. Expression and potential roles of sodium-potassium ATPase and E-cadherin in human gastric adenocarcinoma. PLoS One. 2017;12:e0183692. doi:10.1371/journal.pone.018369228832634
  • Ramírez A, Vera E, Gamboa-Domínguez A, Lambert P, Gariglio P, Camacho J. Calcium-activated potassium channels as potential early markers of human cervical cancer. Oncol Lett. 2018;15:7249–7254. doi:10.3892/ol.2018.818729725443
  • Kolanjiappan K, Manoharan S, Kayalvizhi M. Measurement of erythrocyte lipids, lipid peroxidation, antioxidants and osmotic fragility in cervical cancer patients. Clin Chim Acta. 2002;326:143–149. doi:10.1016/S0009-8981(02)00300-512417105
  • Wilson FP, Berns JS. Tumor lysis syndrome: new challenges and recent advances. Adv Chronic Kidney Dis. 2014;21:18–26. doi:10.1053/j.ackd.2013.07.00124359983
  • Mirrakhimov AE, Ali AM, Khan M, Barbaryan A. Tumor lysis syndrome in solid tumors: an up to date review of the literature. Rare Tumors. 2014;6:5389. doi:10.4081/rt.2014.538925002953
  • Erikssen J, Skrede S. Serum lipids and latent coronary insufficiency. Scand J Clin Lab Invest. 1977;37:243–250. doi:10.1080/00365517709091489616050
  • Erikssen G, Liestøl K, Bjørnholt J, Thaulow E, Sandvik L, Erikssen J. Changes in physical fitness and changes in mortality. Lancet. 1998;352:759–762. doi:10.1016/S0140-6736(98)02268-59737279
  • Falk RS, Tretli S, Paulsen JE, Sandvik L, Erikssen J, Heir T. Response to intravenous glucose-tolerance test and risk of cancer: a long-term prospective cohort study. EBio Med. 2017;21:117–122.
  • Larsen IK, Småstuen M, Johannesen TB, et al. Data quality at the cancer registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer. 2009;45:1218–1231. doi:10.1016/j.ejca.2008.10.03719091545
  • Gumz ML, Rabinowitz L, Wingo CS. An integrated view of potassium homeostasis. N Engl J Med. 2015;373:60–72. doi:10.1056/NEJMra131334126132942
  • Adrogué HJ, Madias NE. Hyopnatremia. N Engl J Med. 2000;342:1581–1589. doi:10.1056/NEJM20000525342210710824078
  • Adrogué HJ, Madias NE. Hypernatremia. N Engl J Med. 2000;342:1493–1499. doi:10.1056/NEJM20000518342200610816188
  • StataCorp. Stata Statistical Software: Release 15. College Station, TX: StataCorp LCC; 2017.
  • Eil R, Vodnala SK, Clever D, et al. Ionic immune suppression within the tumour microenvironment limits T cell effector function. Nature. 2016;537:539–543. doi:10.1038/nature1936427626381
  • Mooi WJ, Peeper DS. Oncogene-induced cell senescence–halting on the road to cancer. N Engl J Med. 2006;355:1037–1046. doi:10.1056/NEJMra06228516957149
  • Friberg S, Mattson S. On the growth rates of human malignant tumors: implications for medical decision making. J Surg Oncol. 1997;65:284–297. doi:10.1002/(ISSN)1096-90989274795
  • Gaukrodger N, Avery PJ, Keavney B. Plasma potassium level is associated with common genetic variation in the beta-subunit of the epithelial sodium channel. Am J Physiol Regul Integr Comp Physiol. 2008;294:R1068–72. doi:10.1152/ajpregu.00732.200718184758
  • Abbott GW. Biology of the KCNQ1 potassium channel. New J Sci. 2014;2014:1–26. doi:10.1155/2014/237431
  • den Uil SH, Coupé VM, Linnekamp JF, et al. Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence. Br J Cancer. 2016;115:1565–1574. doi:10.1038/bjc.2016.37627855440
  • Than BL, Goos JA, Sarver AL, et al. The role of KCNQ1 in mouse and human gastrointestinal cancers. Oncogene. 2014;33:3861–3868. doi:10.1038/onc.2013.35023975432
  • Kuruma S, Egawa N, Kurata M, et al. Case-control study of diabetes-related genetic variants and pancreatic cancer risk in Japan. World J Gastroenterol. 2014;20:17456–17462. doi:10.3748/wjg.v20.i46.1745625516658
  • Heir T, Falk RS, Robsahm TE, Sandvik L, Erikssen J, Tretli S. Cholesterol and prostate cancer risk: a long-term prospective cohort study. BMC Cancer. 2016;16:643. doi:10.1186/s12885-016-2691-527535659